Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1

Coronary heart disease and type-2 diabetes are both major global health burdens associated with an increased risk of myocardial infarction (MI). Following MI, ischaemia-reperfusion injury (IRI) remains a significant contributor to myocardial injury at the cellular level. Research has focussed on ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Sophie J, McCormick, Liam M, Dutka, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893610/
https://www.ncbi.nlm.nih.gov/pubmed/24410815
http://dx.doi.org/10.1186/1475-2840-13-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893610/
https://www.ncbi.nlm.nih.gov/pubmed/24410815
http://dx.doi.org/10.1186/1475-2840-13-12

Ejemplares similares